The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans.
about
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertensionPrevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertension.Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BK(Ca) channels and inhibition of neurotransmitter release.Recent advances in asthma.The effect of vasoactive intestinal peptide on smooth muscle tone and mucus secretion from the ferret trachea.Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo.Pulmonary clearance of vasoactive intestinal peptide.Regulatory peptides in the respiratory tract of Macaca fascicularisEffect of peptide histidine valine on cardiovascular and respiratory function in normal subjects.Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP.Effect of infused vasoactive intestinal peptide on airway function in normal subjectsPotentiation of the bronchoprotective effects of vasoactive intestinal peptide, isoprenaline, and theophylline against histamine challenge in anaesthetised guinea pigs by adrenomedullin.Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4.Inhibition of bronchoconstriction by pituitary adenylate cyclase activating polypeptide (PACAP 1-27) in guinea-pigs in vivo.Human mast cell tryptase isoforms: separation and examination of substrate-specificity differences.Clinical pharmacology and therapeutics.
P2860
Q34985266-2FAFD316-B0D9-4067-BAF3-FA32D5136096Q34988852-11EAA4B1-45F3-4ABE-8B3E-3178D730573EQ35028365-6F2A9A47-1A82-4F1D-9B99-110870F2F7E5Q35277314-944B0943-3889-4DA8-9043-D521BDB2F999Q35754706-DFF17B42-52C6-44A9-B426-B31373ADB7BCQ35756036-6938D0E0-EEF6-4DEE-8945-C2D4C0D9DB50Q36151998-D60956AD-8C2D-4B6A-A8D7-7273163C5EBDQ36167555-042A67B1-C874-46E5-B308-9950B6D646DBQ36189195-FC00B882-C7EC-40CD-962B-8E6FA76C2FD1Q36329443-DF2E9DEC-4DC3-4648-97E4-459932E79F67Q41125885-1A67D5E5-C268-47F6-96F5-CADD852B13D4Q41208639-FE659BB0-C841-4511-A40B-E4163F2F1304Q41836317-955406AE-5AD1-4EE1-9953-7CD2179232EEQ42039126-F963BFEB-FCE4-42A5-935B-DEF0532DC4BEQ42077375-4C57C993-74CA-42F5-AA2A-049E68AFB1C2Q43263960-9970F6CF-6CB9-4A51-98C9-26C09C3F037B
P2860
The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
The effect of inhaled vasoacti ...... tivity to histamine in humans.
@en
The effect of inhaled vasoacti ...... tivity to histamine in humans.
@nl
type
label
The effect of inhaled vasoacti ...... tivity to histamine in humans.
@en
The effect of inhaled vasoacti ...... tivity to histamine in humans.
@nl
prefLabel
The effect of inhaled vasoacti ...... tivity to histamine in humans.
@en
The effect of inhaled vasoacti ...... tivity to histamine in humans.
@nl
P1476
The effect of inhaled vasoacti ...... tivity to histamine in humans.
@en
P2093
P304
P356
10.1164/ARRD.1984.130.2.162
P577
1984-08-01T00:00:00Z